ZA200606661B - Modulation of peroxisome proliferation-activated receptors - Google Patents

Modulation of peroxisome proliferation-activated receptors

Info

Publication number
ZA200606661B
ZA200606661B ZA200606661A ZA200606661A ZA200606661B ZA 200606661 B ZA200606661 B ZA 200606661B ZA 200606661 A ZA200606661 A ZA 200606661A ZA 200606661 A ZA200606661 A ZA 200606661A ZA 200606661 B ZA200606661 B ZA 200606661B
Authority
ZA
South Africa
Prior art keywords
modulation
activated receptors
peroxisome proliferation
peroxisome
proliferation
Prior art date
Application number
ZA200606661A
Other languages
English (en)
Inventor
Lin Rong-Hwa
Chuang Lee-Ming
Original Assignee
Abgenomics Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abgenomics Corp filed Critical Abgenomics Corp
Publication of ZA200606661B publication Critical patent/ZA200606661B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0006—Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70567—Nuclear receptors, e.g. retinoic acid receptor [RAR], RXR, nuclear orphan receptors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Physics & Mathematics (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
ZA200606661A 2005-08-12 2006-08-11 Modulation of peroxisome proliferation-activated receptors ZA200606661B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US70789705P 2005-08-12 2005-08-12

Publications (1)

Publication Number Publication Date
ZA200606661B true ZA200606661B (en) 2008-05-28

Family

ID=37737230

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200606661A ZA200606661B (en) 2005-08-12 2006-08-11 Modulation of peroxisome proliferation-activated receptors

Country Status (16)

Country Link
US (1) US20070037193A1 (xx)
EP (1) EP1803809A3 (xx)
JP (1) JP2007061093A (xx)
KR (1) KR20080014936A (xx)
CN (1) CN1916167A (xx)
AR (1) AR054909A1 (xx)
AU (1) AU2006203479A1 (xx)
BR (1) BRPI0603206A (xx)
CA (1) CA2553115A1 (xx)
CO (1) CO5780135A1 (xx)
IL (1) IL177407A0 (xx)
MX (1) MXPA06009161A (xx)
NO (1) NO20063652L (xx)
SG (1) SG130141A1 (xx)
TW (1) TW200741003A (xx)
ZA (1) ZA200606661B (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2552108T3 (es) * 2005-03-11 2015-11-25 Howard Florey Institute Pty Ltd Compuestos flavonoides y usos de los mismos
WO2009026657A1 (en) * 2007-08-29 2009-03-05 The University Of Sydney Flavonoid ppar agonists
AU2009259543B2 (en) * 2008-05-28 2015-09-03 Basf Se Means and methods for assessing increased peroxisomal proliferation
US20110306605A1 (en) * 2008-12-22 2011-12-15 Sloan-Kettering Institute For Cancer Research Coumarin-based compounds for the treatment of alzheimer's disease and cancer
EP2389459B1 (en) * 2009-01-21 2014-03-26 George Atanasoff Methods and systems for control of a surface modification process
EA015364B1 (ru) * 2009-03-18 2011-06-30 Учреждение Российской Академии Наук Институт Элементоорганических Соединений Им. А.Н. Несмеянова Ран (Инэос Ран) 6,6'-диизопропил-8,8'-диметил-2,2'-динитро-3,3'-бис(трифторметил)- 3н,3'н-[9,9']ди[бензо(f)хроменил]-5,10,5',10'-тетраол, обладающий противоопухолевой и противогрибковой активностью, и способ его получения
CA2767616A1 (en) * 2009-07-09 2011-01-13 The Scripps Research Institute Gene expression profiles associated with chronic allograft nephropathy
CN101948458B (zh) * 2010-09-07 2012-11-07 中国药科大学 具有抗肿瘤活性的黄芩素衍生物及在医药上的应用
CN102964322A (zh) * 2012-12-12 2013-03-13 中国药科大学 异黄酮或类黄酮脂肪醚类衍生物、其制备方法和医药用途
JP7029777B2 (ja) * 2016-03-28 2022-03-04 国立大学法人金沢大学 アンドロゲン依存性又は非依存性前立腺癌細胞の抑制用の組成物及びそれを含有する前立腺癌の医薬製剤
CN107496414A (zh) * 2017-09-21 2017-12-22 上海华堇生物技术有限责任公司 柽柳黄素的药物用途
CN112645922B (zh) * 2020-12-24 2022-01-07 中国人民解放军空军军医大学 香豆素类化合物、制备方法及应用
CN115894422A (zh) * 2022-12-26 2023-04-04 上海中医药大学 PPARγ激动剂及其组合和应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2543550B1 (fr) * 1983-04-01 1985-08-09 Cortial Nouveaux derives de la tetrahydroxy-3', 4',5,7 flavone, leur methode de preparation et leur emploi therapeutique
US4587260A (en) * 1984-06-21 1986-05-06 Warner-Lambert Company Dibenzalacetone and benzylcinnamate as non-steroidal anti-inflammatory compounds and compositions thereof
DE69130586T2 (de) * 1990-05-01 1999-06-17 R-Tech Ueno, Ltd., Osaka Behandlung von Pankreaskrankheit mit 15-keto-Prostaglandin E-Derivaten
CA2046069C (en) * 1990-07-10 2002-04-09 Ryuji Ueno Treatment of inflammatory diseases with 15-keto-prostaglandin compounds
ES2181923T3 (es) * 1995-11-17 2003-03-01 Upjohn Co 4-hidroxicumarin-3-carboxamidas para el tratamiento de la diabet es mellitus no dependiente de la insulina.
AU5034200A (en) * 1999-05-20 2000-12-12 Incyte Genomics, Inc. Oxidoreductase proteins
EP1267882B1 (en) * 2000-03-24 2009-04-15 Sucampo AG Prostaglandins for the treatment of eye disease caused by light irradiation like photoretinitis
EP1402026A2 (en) * 2000-04-18 2004-03-31 Millennium Pharmaceuticals, Inc. 39228, a human alcohol dehydrogenase and uses therefor
WO2001080855A1 (en) * 2000-04-27 2001-11-01 Geron Corporation Telomerase inhibitors and methods of their use
US7326734B2 (en) * 2003-04-01 2008-02-05 The Regents Of The University Of California Treatment of bladder and urinary tract cancers

Also Published As

Publication number Publication date
CA2553115A1 (en) 2007-02-12
AR054909A1 (es) 2007-07-25
CO5780135A1 (es) 2007-07-31
BRPI0603206A (pt) 2007-05-15
NO20063652L (no) 2007-02-13
EP1803809A3 (en) 2007-12-19
JP2007061093A (ja) 2007-03-15
US20070037193A1 (en) 2007-02-15
MXPA06009161A (es) 2007-03-21
IL177407A0 (en) 2006-12-31
KR20080014936A (ko) 2008-02-15
TW200741003A (en) 2007-11-01
AU2006203479A1 (en) 2007-03-01
SG130141A1 (en) 2007-03-20
CN1916167A (zh) 2007-02-21
EP1803809A2 (en) 2007-07-04

Similar Documents

Publication Publication Date Title
ZA200606661B (en) Modulation of peroxisome proliferation-activated receptors
EP1771582A4 (en) MODULATORS OF ODOR RECEIVERS
IL179376A0 (en) Compounds and compositions as ppar modulators
IL192327A0 (en) Modulators of muscarinic receptors
EP1898834A4 (en) SELF-ADJUSTABLE ENDO-URETRAL DEVICE AND METHODS OF USE
GB0522477D0 (en) Modulator
IL189383A0 (en) Derivatives of 4-piperazin-1-yl
IL205536A0 (en) Modulation of factor 7 expression
EP1745027A4 (en) COMPOUNDS AND COMPOSITIONS AS PPAR MODULATORS
EP1928359A4 (en) JOINT ARTHROPLASTIEVORRICHTUNGEN
IL179375A0 (en) Compounds and compositions as ppar modulators
BRPI0815277A2 (pt) "monitores de particulado"
EP1756062A4 (en) COMPOUNDS AND COMPOSITIONS AS PPAR MODULATORS
GB0808478D0 (en) Airbrush
AP2008004487A0 (en) 3-aminocyclopentanecarboxamides as modulators of chemokine receptors
MA28361A1 (fr) Modulateurs des recepteurs d'androgenes
DK2392335T3 (en) Use of 24-norUDCA
HK1114411A1 (en) Fixture joint
SG138604A1 (en) Modulation of peroxisome proliferator-activated receptors
GB0503536D0 (en) Joint devices
BRPI0816545A2 (pt) "receptáculo inflável"
IL187530A0 (en) Activator for peroxisome proliferator-activated receptor
EP1931370A4 (en) USE OF DES-ASPARTATE-ANGIOTENSIN I
ZA200608611B (en) Compounds and compositions as ppar modulators
EP1923587A4 (en) SEAL